| 题名 | Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe |
| 作者 | Wang, Weizhi1,2; Ma, Zhuoran2; Zhu, Shoujun2; Wan, Hao2; Yue, Jingying2; Ma, Huilong3 ; Ma, Rui3 ; Yang, Qinglai3; Wang, Zihua1,4; Li, Qian4; Qian, Yixia1; Yue, Chunyan1; Wang, Yuehua1; Fan, Linyang1; Zhong, Yeteng2; Zhou, Ying2; Gao, Hongpeng2; Ruan, Junshan2; Hu, Zhiyuan1,5,6 ; Liang, Yongye3![]() ; Dai, Hongjie2
|
| 通讯作者 | Hu, Zhiyuan; Liang, Yongye; Dai, Hongjie |
| 发表日期 | 2018-05-29
|
| DOI | |
| 发表期刊 | |
| ISSN | 0935-9648
|
| EISSN | 1521-4095
|
| 卷号 | 30期号:22 |
| 摘要 | In vivo molecular imaging of tumors targeting a specific cancer cell marker is a promising strategy for cancer diagnosis and imaging guided surgery and therapy. While targeted imaging often relies on antibody-modified probes, peptides can afford targeting probes with small sizes, high penetrating ability, and rapid excretion. Recently, in vivo fluorescence imaging in the second near-infrared window (NIR-II, 1000-1700 nm) shows promise in reaching sub-centimeter depth with microscale resolution. Here, a novel peptide (named CP) conjugated NIR-II fluorescent probe is reported for molecular tumor imaging targeting a tumor stem cell biomarker CD133. The click chemistry derived peptide-dye (CP-IRT dye) probe afforded efficient in vivo tumor targeting in mice with a high tumor-to-normal tissue signal ratio (T/NT > 8). Importantly, the CP-IRT probes are rapidly renal excreted (approximate to 87% excretion within 6 h), in stark contrast to accumulation in the liver for typical antibody-dye probes. Further, with NIR-II emitting CP-IRT probes, urethra of mice can be imaged fluorescently for the first time noninvasively through intact tissue. The NIR-II fluorescent, CD133 targeting imaging probes are potentially useful for human use in the clinic for cancer diagnosis and therapy. |
| 关键词 | |
| 相关链接 | [来源记录] |
| 收录类别 | |
| 语种 | 英语
|
| 重要成果 | NI期刊
; NI论文
|
| 学校署名 | 通讯
|
| 资助项目 | Shenzhen Peacock Program[KQTD20140630160825828]
|
| WOS研究方向 | Chemistry
; Science & Technology - Other Topics
; Materials Science
; Physics
|
| WOS类目 | Chemistry, Multidisciplinary
; Chemistry, Physical
; Nanoscience & Nanotechnology
; Materials Science, Multidisciplinary
; Physics, Applied
; Physics, Condensed Matter
|
| WOS记录号 | WOS:000434034100025
|
| 出版者 | |
| EI入藏号 | 20182305274062
|
| EI主题词 | Antibodies
; Diagnosis
; Diseases
; Fluorescence imaging
; Infrared devices
; Mammals
; Peptides
; Physiology
; Probes
; Stem cells
; Tumors
|
| EI分类号 | Bioengineering and Biology:461
; Imaging Techniques:746
|
| ESI学科分类 | MATERIALS SCIENCE
|
| 来源库 | Web of Science
|
| 引用统计 |
被引频次[WOS]:112
|
| 成果类型 | 期刊论文 |
| 条目标识符 | http://kc.sustech.edu.cn/handle/2SGJ60CL/27694 |
| 专题 | 工学院_材料科学与工程系 |
| 作者单位 | 1.Natl Ctr Nanosci & Technol China, CAS Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, CAS Key Lab Standardizat & Measurement Nanotechno, Beijing 100190, Peoples R China 2.Stanford Univ, Dept Chem, Stanford, CA 94305 USA 3.South Univ Sci & Technol China, Dept Mat Sci & Engn, Shenzhen 518055, Peoples R China 4.Chinese Acad Sci, Inst Chem, Beijing 100190, Peoples R China 5.Univ Chinese Acad Sci, Sinodanish Coll, Beijing 100049, Peoples R China 6.Fujian Med Univ, Sch Basic Med Sci, Ctr Neurosci Res, Fuzhou 350108, Fujian, Peoples R China |
| 通讯作者单位 | 材料科学与工程系 |
| 推荐引用方式 GB/T 7714 |
Wang, Weizhi,Ma, Zhuoran,Zhu, Shoujun,et al. Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe[J]. ADVANCED MATERIALS,2018,30(22).
|
| APA |
Wang, Weizhi.,Ma, Zhuoran.,Zhu, Shoujun.,Wan, Hao.,Yue, Jingying.,...&Dai, Hongjie.(2018).Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe.ADVANCED MATERIALS,30(22).
|
| MLA |
Wang, Weizhi,et al."Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe".ADVANCED MATERIALS 30.22(2018).
|
| 条目包含的文件 | 条目无相关文件。 | |||||
|
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论